You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Luspatercept for treating anaemia caused by myelodysplastic syndromes (including review of TA844) [ID6696]

  • Awaiting development
  • Reference number: GID-TA11914
  • Expected publication date: TBC
  • Project information
  • Project documents

26943-Luspatercept-for-Anaemia-Due-to-Myelodysplastic-Syndromes-V1.0-OCT2025-NON-CONF.pdf

Back to top